Breaking News

Sanofi Invests $679M in Two French Vaccine Sites

Will create a state-of-the-art vaccine production site and a new research center dedicated to vaccines

By: Contract Pharma

Contract Pharma Staff

Sanofi has unveiled plans on how the company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks. The company will invest $679.4 million to create a new production site and research center in France with both dedicated to vaccines.   “Sanofi’s heart beats in France. We have a long history and exceptional teams working throughout the country, embodying our strong values. By investing in a ne...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters